STOCK TITAN

REVVITY (NYSE: RVTY) CFO granted RSUs, stock options and surrenders shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

REVVITY, INC. executive Maxwell Krakowiak, Senior Vice President and Chief Financial Officer, reported multiple equity transactions dated February 4, 2026. He surrendered 708 shares of common stock at $101.13 per share to cover tax withholding tied to previously granted restricted stock units.

He also acquired 7,262 time-based restricted stock units at no cost, bringing his directly held common stock to 18,771 shares. In addition, he received a non-qualified stock option for 20,771 shares at an exercise price of $103.395, scheduled to vest in three equal annual installments beginning on the first anniversary of grant. The filing also corrects an earlier vesting schedule disclosure due to an administrative error.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krakowiak Maxwell

(Last) (First) (Middle)
77 4TH AVENUE

(Street)
WALTHAM MA 02451-7567

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REVVITY, INC. [ RVTY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Please See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/04/2026 F 708(1)(2) D $101.13 11,509 D
Common Stock 02/04/2026 A 7,262(3) A $0 18,771 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
NQ Stock Option (right to buy) $103.395 02/04/2026 A 20,771 (4) 02/04/2033 Common Stock 20,771 $0 20,771 D
Explanation of Responses:
1. The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
2. These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock units originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement.
3. Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
4. This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
Remarks:
Senior Vice President and Chief Financial Officer
s/ John L. Healy (POA on file) for Maxwell Krakowiak 02/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Revvity Inc

NYSE:RVTY

RVTY Rankings

RVTY Latest News

RVTY Latest SEC Filings

RVTY Stock Data

11.28B
113.02M
0.34%
100.5%
5.26%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
WALTHAM